Literature DB >> 17691945

Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents.

Marko Oblak1, Miha Kotnik, Tom Solmajer.   

Abstract

DNA gyrase is an attractive and well established target for the development of antibacterial agents. This bacterial enzyme, whose biological function is to control the topological state of DNA molecules, consists of two catalytic subunits; GyrA is responsible for DNA breakage and reunion, while the subunit GyrB contains the ATP-binding site. Coumarins and cyclothialidines are natural products that inhibit the ATPase activity of DNA gyrase by blocking the binding of ATP to subunit GyrB. The mechanism of action of these compounds was exhaustively characterized by biochemical methods and supported by protein crystallography. The abundance of crystallographic data on the N-terminal domain of GyrB in its complexes with various ligands has enabled the structure-based design of novel efficient chemotypes as inhibitors of the ATPase domain. This review summarizes the discovery of ATPase inhibitors of DNA gyrase B in the last decade and their development as potential antibacterial agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17691945     DOI: 10.2174/092986707781368414

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  25 in total

Review 1.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

Review 2.  In front of and behind the replication fork: bacterial type IIA topoisomerases.

Authors:  Claudia Sissi; Manlio Palumbo
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

Review 3.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.

Authors:  Xiaojie Huang; Junsong Guo; Qi Liu; Qiong Gu; Jun Xu; Huihao Zhou
Journal:  Medchemcomm       Date:  2018-07-04       Impact factor: 3.597

5.  Thermodynamic computational approach to capture molecular recognition in the binding of different inhibitors to the DNA gyrase B subunit from Escherichia coli.

Authors:  Liane Saíz-Urra; Miguel Ángel Cabrera Pérez; Matheus Froeyen
Journal:  J Mol Model       Date:  2013-04-30       Impact factor: 1.810

6.  Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors.

Authors:  Jing Zhang; Qingyi Yang; Jan Antoinette C Romero; Jason Cross; Bin Wang; Katherine M Poutsiaka; Felix Epie; Douglas Bevan; Yuchuan Wu; Terence Moy; Anu Daniel; Brian Chamberlain; Nicole Carter; Joseph Shotwell; Anu Arya; Vipul Kumar; Jared Silverman; Kien Nguyen; Chester A Metcalf; Dominic Ryan; Blaise Lippa; Roland E Dolle
Journal:  ACS Med Chem Lett       Date:  2015-09-08       Impact factor: 4.345

Review 7.  The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota.

Authors:  Małgorzata Makarewicz; Iwona Drożdż; Tomasz Tarko; Aleksandra Duda-Chodak
Journal:  Antioxidants (Basel)       Date:  2021-01-28

8.  Evaluating the genotoxicity of topoisomerase-targeted antibiotics.

Authors:  Daniel J Smart; Anthony M Lynch
Journal:  Mutagenesis       Date:  2011-12-07       Impact factor: 3.000

9.  Quantitative structure-activity relationship study of antitubercular fluoroquinolones.

Authors:  Nikola Minovski; Marjan Vračko; Tom Solmajer
Journal:  Mol Divers       Date:  2010-03-14       Impact factor: 2.943

10.  Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrB.

Authors:  C Sissi; E Vazquez; A Chemello; L A Mitchenall; A Maxwell; M Palumbo
Journal:  Antimicrob Agents Chemother       Date:  2009-10-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.